In this study, we demonstrated the molecular mechanism and clinical implication of rs67311347 in the development of RCC, which functioned as an enhancer element and regulated the expression of lncRNA ENTPD3-AS1 through the miR-155-5p/HIF-1α pathway. Here, ENTPD3 is linked to renal cell carcinoma.